Latest News
The UK Government has named two leaders in dementia research to spearhead its ambitious national Mission to tackle dementia, launched in memory of the late Dame Barbara Windsor. Hilary Evans, chief executive of Alzheimer’s Research UK, and Nadeem Sarwar, currently a senior leader at Eisai, one of the world’s leading pharmaceutical companies, have been appointed [...]
Digital health company, Biostarks, has announced the launch of two new at-home test kits to measure a range of indicators for optimum health and longevity. After entering the nutrition and sport markets with two respective at-home test kits leveraging its mass-spectrometry platform, the company is expanding its offering in the fast-growing longevity market with two [...]
Early trial results give hope for a new potential dyskinesia treatment for people with Parkinson’s disease. A new clinical trial, carried out by Neurolixis and made possible by co-funding from the Parkinson’s Virtual Biotech and The Michael J Fox Foundation for Parkinson’s Research (MJFF), shows that the drug NLX-112 is safe and effective in reducing [...]
Researchers believe that a decline in dual-task walking performance in middle age may be an early indicator of accelerated brain ageing and increased risk of falls and dementia. Walking is a complex task that is most commonly performed while completing other tasks like talking, reading signs, or making decisions. For most, after the age of [...]
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep forming incurable secondary tumours. The research, funded by Breast Cancer Now, reveals the mechanism that triggers this breast cancer 'time bomb' – and suggests a strategy to defuse it. Patients with oestrogen receptor positive (ER+) [...]
The Canadian government has announced a $30 million investment to continue to help accelerate innovation in ageing and brain health. As part of Brain Awareness Week and Brain Health Awareness Month, Canada’s Ministry of Health has announced a $30 million investment to continue supporting the implementation of Canada's National Dementia Strategy. This investment will be [...]
BlueRock Therapeutics will leverage a data platform from software company Rune Labs to monitor Parkinson's disease patients in a new observational study. BlueRock will use StriveStudy, Rune Labs' clinical trial platform featuring data collection and patient monitoring tools, to capture a holistic picture of Parkinson's disease activity and to better engage patients in the study. [...]
A new study has found that yoga may help prevent frailty and improve strength and gait speed in older adults who are inactive. A systematic review of 33 randomised controlled trials (RCTs) found that yoga improved gait speed and lower extremity strength in inactive older people. However, yoga did not seem to offer a benefit [...]
A new report from the Alzheimer’s Association highlights the need for better patient-doctor communication as new treatments for the disease become available. While recent advancements in treatment of early-stage Alzheimer's are providing hope to millions living with memory loss and early cognitive decline, a new report finds too often individuals with memory concerns and their [...]
Scientists have shed new light on ageing processes in the brain, offering new hope for the treatment of neurological diseases. By linking the increased presence of specialised immune cells to conditions such as Alzheimer’s disease and traumatic brain injury for the first time, scientists from the Trinity Biomedical Sciences Institute (TBSI) have unearthed a possible [...]
